Featured
Featured Videos
SAN DIEGO – At the American Association for Cancer Research (AACR) Annual Meeting 2026, the conversation around AI-driven cancer research has moved decisively past theory. Now the focus is on what’s being deployed and how to gain researchers’ and clinicians’ trust.
Fay Lin, PhD, senior editor, technology at GEN, and Jonathan D. Grinstein, PhD, North American editor at Inside Precision Medicine, discuss how AI is increasingly embedded across cancer research areas, from organoid models to pathology. Yet challenges such as data integration, longitudinal patient tracking, and clinician confidence continue to hinder its impact on patient outcomes.
AACR 2026 Video Update: Cancer Research Edges Toward an AI-Driven Era
The American Association for Cancer Research (AACR) meeting is off and running in San Diego. Julianna LeMieux, PhD, Deputy Editor in Chief at GEN, and Damian Doherty, Editor in Chief at Inside Precision Medicine, are on the ground—in the talks, expo hall, and press room, covering as much of the news as they can. Here, they take a moment to chat about the first few days at the meeting.
AACR 2026: A Video Update from San Diego
The month of May brings with it spring and an abundance of new growth and life. In this issue of GEN we celebrate the abundance of stories highlighting progress and growth in the field of cell and gene therapy in a special American Society of Gene & Cell Therapy (ASGCT) issue. Ahead of the 28th ASGCT meeting, GEN spoke with the organization’s leadership about their perspectives on scientific advances, new tools, and the current state of funding constraints. Other topics in this issue include the ongoing efforts in CAR T-cell therapy, innovative delivery techniques, including high-tech nanoparticles and electroporation devices, and progress in improving AAV-based gene therapies. Additionally, the magazine includes a story discussing how current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products. Finally, the May issue also includes “The Top 10 Best-Selling Gene Therapies.”
